Biblio

2022
Shah SH, Schiapparelli LM, Ma Y, Yokota S, Atkins M, Xia X, Cameron EG, Huang T, Saturday S, Sun CB, et al. Quantitative transportomics identifies Kif5a as a major regulator of neurodegeneration. Elife. 2022;11.
Tiwari S, Kharbanda S, Singh H. Quatramer™ Mediated Codelivery of PI3-Kδ/HDAC6 Dual Inhibitor Augments the Anti-Cancer Efficacy of Epirubicin in Breast Cancer. Eur J Pharm Biopharm. 2022.
Azizi E, Fouladdel S, Movahhed TKomeili, Modaresi F, Barzegar E, Ghahremani MH, Ostad SNaser, Atashpour S. Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells. Asian Pac J Cancer Prev. 2022;23(12):4145-4154.
Xie XP, Laks DR, Sun D, Ganbold M, Wang Z, Pedraza AM, Bale T, Tabar V, Brennan C, Zhou X, et al. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. Dev Cell. 2022;57(1):32-46.e8.
Morishima Y, Morishima S, Stevenson P, Kodera Y, Horowitz M, McKallor C, Malkki M, Spellman SR, Gooley T, Petersdorf EW. Race and Survival in Unrelated Hematopoietic-cell Transplantation. Transplant Cell Ther. 2022.
Liu T, Phan L, Chen-Sankey J, Ajith A, Hacker K, Jewett B, Choi K. Race, Concern About COVID-19 Discrimination, and Cigarette Smoking Behavior: Comparison Between US Asian and White Adults Who Use Commercial Tobacco. J Racial Ethn Health Disparities. 2022.
Miller YMarie, Butler-Foster T, Montemayor-Garcia C. Racial differences in transfusion practices: Time to address structural racism. Transfusion. 2022;62(8):1471-1476.
Deng P, Wang Z, Chen J, Liu S, Yao X, Liu S, Liu L, Yu Z, Huang Y, Xiong Z, et al. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. J Clin Invest. 2022.
Bogart JA, Waqar SN, Mix MD. Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer. J Clin Oncol. 2022:JCO2101639.
Hardy-Abeloos C, Gerber N, Shaikh F. Radiation Recall Dermatitis after Donor Lymphocyte Infusion for Adult T cell Leukemia Lymphoma post Allogeneic Stem Cell Transplant. Pract Radiat Oncol. 2022.
Imanishi M, Cheng H, Kotla S, Deswal A, Le N-T, Chini E, Ko KAe, Samanthapudi VSK, Lee L-L, Herrmann J, et al. Radiation therapy induces immunosenescence mediated by p90RSK. Front Cardiovasc Med. 2022;9:988713.
Wang B, Hu J, Zhang J, Zhao L. Radiation therapy regulates TCF-1 to maintain CD8+T cell stemness and promotes anti-tumor immunotherapy. Int Immunopharmacol. 2022;107:108646.
Kiumarsi A, Mousavi SAli, Kasaeian A, Rostami T, Rad S, Ghavamzadeh A, Mousavi SAsadollah. Radiation-free Reduced-intensity Hematopoietic Stem Cell Transplantation with In-Vivo T-cell Depletion from Matched Related and Unrelated Donors for Fanconi Anemia: Prognostic Factor Analysis. Exp Hematol. 2022.
Bonham LW, Geier EG, Sirkis DW, Leong JK, Ramos EMarisa, Wang Q, Karydas A, Lee SE, Sturm VE, Sawyer RP, et al. Radiogenomics of expansion carriers reveals global transposable element de-repression and enables prediction of thalamic atrophy and clinical impairment. J Neurosci. 2022.
Su G-H, Xiao Y, Jiang L, Zheng R-C, Wang H, Chen Y, Gu Y-J, You C, Shao Z-M. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer. J Transl Med. 2022;20(1):471.
Nishiga Y, Drainas AP, Baron M, Bhattacharya D, Barkal AA, Ahrari Y, Mancusi R, Ross JB, Takahashi N, Thomas A, et al. Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect. Nat Cancer. 2022.
Park J, Choi J, Cho I, Sheen YYhong. Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor. Sci Rep. 2022;12(1):16104.
Jin M, Alam MMaraj, Liu AY-C, Jiang P. Rag2 accelerates lipofuscin accumulation in the brain: Implications for human stem cell brain transplantation studies. Stem Cell Reports. 2022.
Al-Attar R, Storey KB. RAGE management: ETS1- EGR1 mediated transcriptional networks regulate angiogenic factors in wood frogs. Cell Signal. 2022:110408.
Coulson ABeth, Royle K-L, Pawlyn C, Cairns DA, Hockaday A, Bird J, Bowcock S, Kaiser M, de Tute R, Rabin N, et al. railty-adjusted therapy n ransplant on-ligible patient with newly diagnoed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial. BMJ Open. 2022;12(6):e056147.
Suda S, Nito C, Ihara M, Iguchi Y, Urabe T, Matsumaru Y, Sakai N, Kimura K. Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR). BMJ Open. 2022;12(5):e054269.
Jensen JBrorson, Dollerup OLindgård, Møller ABuch, Billeskov TB, Dalbram E, Chubanava S, Damgaard MV, Dellinger RW, Trošt K, Moritz T, et al. A randomized placebo-controlled trial of nicotinamide riboside+pterostilbene supplementation in experimental muscle injury in elderly subjects. JCI Insight. 2022.
Bowdish ME, Barkauskas CE, Overbey JR, Gottlieb RL, Osman K, Duggal A, Marks ME, Hupf J, Fernandes E, Leshnower BG, et al. A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe ARDS From COVID-19. Am J Respir Crit Care Med. 2022.
Jiang Y, Li X, Guo T, Lu W-J, Ma S, Chang Y, Song Y, Zhang S, Bai R, Wang H, et al. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2022.
Ren X, Lei W, Huang S, Shi D, Li X. Rapamycin Treatment Is Beneficial for the Generation of Rabbit-Induced Pluripotent Stem-Like Cells. Cell Reprogram. 2022.

Pages